ADMA BIOLOGICS, INC. (ADMA) › Net IncomeADMA BIOLOGICS, INC. (ADMA) — Net IncomeAnnual figures by fiscal year, from SEC filings.2011: -$5.90M2012: -$7.30M2013: -$15.53M2014: -$16.81M2015: -$17.97M2016: -$19.52M2017: -$43.76M2018: -$65.74M2019: -$48.28M2020: -$75.75M2021: -$71.65M2022: -$65.90M2023: -$28.24M2024: $197.67M2025: $146.93M$146.93M2011Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$146.93M-25.7%2024$197.67M+800.0%2023-$28.24M+57.2%2022-$65.90M+8.0%2021-$71.65M+5.4%2020-$75.75M-56.9%2019-$48.28M+26.6%2018-$65.74M-50.2%2017-$43.76M-124.2%2016-$19.52M-8.6%2015-$17.97M-6.9%2014-$16.81M-8.3%2013-$15.53M-112.7%2012-$7.30M-23.7%2011-$5.90M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share